Cytokine Release Syndrome (CRS) After CAR-T: Caregiver Warning Signs

Cytokine Release Syndrome (CRS) After CAR-T: Caregiver Warning Signs
Outpatient CAR-T: What Caregivers Do in the First 30 Days
From Breakthrough to Bedside: The CAR-T Story and UPenn's Legacy | Adam Cohen, MD
Targeted therapies for cancer treatment
Understanding Your Treatment Options for Blood Cancers
Inpatient CAR-T Caregiver Guide: Hospital Stay and First 30 Days at Home
BETA - Axi-Cel (Yescarta) - A CAR-T Cell Product for Lymphoma
BETA - Managing Weight Loss and Quality of Life During GPRC5D-Targeted Therapy
CDC 2026–2027 COVID-19 Vaccines: What Cancer Patients Need to Know

Brighter Days: Dawn's Autologous Stem Cell Transplant Experience
BETA - Managing Taste Changes, Dry Mouth, and Swallowing Problems During GPRC5D-Targeted Therapy
CAR-T Caregiver Logistics: Time Off, Lodging, Driving & Costs
BETA - Lenalidomide (Revlimid) An Immmunomodulatory Drug IMiD for Follicular Lymphoma
Newly Diagnosed Multiple Myeloma: Supportive Care, Infections & IVIG
How Do Doctors Personalize Multiple Myeloma Treatment? Risk, MRD & More